Fig. 6From: Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancerThe correlation of SLC25A10 with the overall survival and molecular functions in patients with ovarian cancer. A Kaplan–Meier survial analysis of SLC25A10 with ovarian cancer using the information from TCGA dataset. Patients are divided into low and high SLC25A10 groups by median expression level. B-D Results of GO analysis showing the consistently altered gene profiles with SLC25A10 in TCGA dataset, including biological process (B), cellular component (C) and molecular function (D)Back to article page